The effect of cannabinoid type 2 receptor agonist on morphine tolerance
Pain highly impacts the quality of life of patients. Morphine is used for pain treatment; however, its side effects, especially morphine tolerance, limit its use in the clinic. The problem of morphine tolerance has plagued health workers and patients for years. Unfortunately, the exact mechanism of...
Main Authors: | Di Cui, Yuanyuan Zhang, Mingyue Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | IBRO Neuroscience Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123022832 |
Similar Items
-
Microinjection of WIN55,212-2 as a Cannabinoid Agonist into the Basolateral Amygdala Induces Sensitization to Morphine in Rats
by: Marzieh Molaei, et al.
Published: (2014-11-01) -
The Interaction Between Spinal PDGFRβ and μ Opioid Receptor in the Activation of Microglia in Morphine-Tolerant Rats
by: Li Z, et al.
Published: (2020-07-01) -
Effects of dezocine on morphine tolerance and opioid receptor expression in a rat model of bone cancer pain
by: Lin-xin Wu, et al.
Published: (2021-10-01) -
Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
by: Zachary W. Reichenbach, et al.
Published: (2022-04-01) -
Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis
by: Jia-Jia Zhang, et al.
Published: (2023-10-01)